A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF NP001 IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND EVIDENCE OF ELEVATED SYSTEMIC INFLAMMATION
Principal Investigator(s)
Jackson,Carlayne E
Funded by
NEURALTUS PHARMACEUTICALS, INC.
Research Start Date
Status
Active